相关实验视频

Updated: Jul 12, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

作为瘤调节剂的DYRK2的功能作用

Yuta Mochimaru¹, Kiyotsugu Yoshida¹

¹Department of Biochemistry, The Jikei University School of Medicine, Tokyo 105-8461, Japan.

Current issues in molecular biology

|October 27, 2023

概括

双重特异性氨酸酸化调节激酶2 (DYRK2) 在癌症中具有双重作用,既起瘤抑制作用,又起瘤基因作用. 需要进一步的研究,特别是使用转基因小鼠,以澄清其在瘤发生中的复杂功能.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
遗传学是一个遗传学.

背景情况:

双特异氨酸酸化调节激酶2 (DYRK2) 涉及至关重要的细胞过程,包括细胞亡,DNA修复,细胞循环调节和胚胎发生.
DYRK2在瘤发生中的作用是复杂的,有相互矛盾的报道表明它可以在不同类型的癌症中充当瘤抑制剂和瘤基因.
了解DYRK2在癌症中的保存功能是具有挑战性的,因为据报道它具有双重作用.

研究的目的:

审查和综合目前对DYRK2在各种人类癌症中的功能的理解.
突出报告的DYRK2函数中的差异,并确定知识差距.
强调需要先进的研究模型来阐明DYRK2的致癌性或瘤抑制作用.

主要方法:

关于研究DYRK2在癌症中的综合文献综述.
分析患者组织样本的研究结果.
评估来自细胞系和异种移植研究的证据.

主要成果:

DYRK2在瘤发生过程中表现出上下文依赖的作用,同时作为瘤抑制剂和瘤基因.
目前使用细胞系和异种移植的研究为DYRK2的体内功能提供了有限的洞察力.
在不同类型的癌症中,报告的DYRK2功能存在显著的变化.

结论:

由于其相互矛盾的功能,DYRK2在癌症中的确切作用仍然难以捉摸.
使用转基因小鼠模型进行进一步的研究对于更深入地了解DYRK2在癌症中的功能双重性至关重要.
澄清DYRK2的机制对于瘤学的潜在治疗策略至关重要.

关键词:

在 DYRK2 的位置上.非固体瘤的非固体瘤.固体瘤是一个固体瘤.

更多相关视频

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Analysis of Cell Cycle Position in Mammalian Cells

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...